Item Infomation
| Title: |
| Outcomes in participants with ventilated nosocomial pneumonia and organ failure treated with ceftolozane/tazobactam versus meropenem: a subset analysis of the phase 3, randomized, controlled ASPECT-NP trial |
| Authors: |
| Ignacio, Martin-Loeches Andrew F., Shorr Richard G., Wunderink |
| Issue Date: |
| 2023 |
| Publisher: |
| Springer |
| Abstract: |
| The pivotal ASPECT-NP trial showed ceftolozane/tazobactam was non-inferior to meropenem for the treatment of ventilated hospital-acquired/ventilator-associated bacterial pneumonia (vHABP/VABP). Here, we evaluated treatment outcomes by degree of respiratory or cardiovascular dysfunction. |
| Description: |
| CC BY |
| URI: |
| https://link.springer.com/article/10.1186/s13613-022-01084-8 https://dlib.phenikaa-uni.edu.vn/handle/PNK/7068 |
| Appears in Collections |
| OER- Y học- Điều dưỡng |
ABSTRACTS VIEWS
103
FULLTEXT VIEWS
44
Files in This Item: